Patient/family views on data sharing in rare diseases: study in the European LeukoTreat project. - Université Clermont Auvergne Accéder directement au contenu
Article Dans Une Revue European Journal of Human Genetics Année : 2016

Patient/family views on data sharing in rare diseases: study in the European LeukoTreat project.

Résumé

The purpose of this study was to explore patient and family views on the sharing of their medical data in the context of compiling a European leukodystrophies database. A survey questionnaire was delivered with help from referral centers and the European Leukodystrophies Association, and the questionnaires returned were both quantitatively and qualitatively analyzed. This study found that patients/families were strongly in favor of participating. Patients/families hold great hope and trust in the development of this type of research. They have a strong need for information and transparency on database governance, the conditions framing access to data, all research conducted, partnerships with the pharmaceutical industry, and they also need access to results. Our findings bring ethics-driven arguments for a process combining initial broad consent with ongoing information. On both, we propose key item-deliverables to database participants.
Fichier principal
Vignette du fichier
Darquy et al.pdf (398.89 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

inserm-01179381 , version 1 (22-07-2015)

Identifiants

Citer

Sylviane Darquy, Grégoire Moutel, Anne-Sophie Lapointe, Diane d'Audiffret, Julie Champagnat, et al.. Patient/family views on data sharing in rare diseases: study in the European LeukoTreat project.: Survey assessing data sharing in leukodystrophies . European Journal of Human Genetics, 2016, 24 (3), pp.338-43. ⟨10.1038/ejhg.2015.115⟩. ⟨inserm-01179381⟩
316 Consultations
219 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More